02.27.26 -- Global Partnerships Drive Biomanufacturing Innovation

Two biopharmaceutical organizations announced a manufacturing agreement during the J.P. Morgan Healthcare Conference in San Francisco to enhance production for an innovative oncology therapy using a proprietary photoimmunotherapy platform.

Integrated antibody discovery services accelerate lead generation and optimization with advanced platforms, bioassays, and pharmacology for diverse biologics modalities.

Gain insight into a CDMO with global, end-to-end mammalian manufacturing solutions, proven expertise, flexible capacity, and a strong track record in regulatory compliance that can support your company's needs.

End-to-end injectable services, a comprehensive approach, and dedication to excellence provide convenient, easy-to-use, patient-centric therapies.

We use our bio-logic brilliance to unravel the complexities of ADCs — empowering companies to accelerate development, enhance manufacturing efficiency, and deliver life-changing therapies.

Our manufacturing units focus on process robustness and consistency to ensure product quality, purity, and efficacy. These facilities feature equipment for animal cell-derived viral and microbial products and clinical trials.

A new chapter outlines system‑level functional testing for elastomeric components used in parenteral packaging, emphasizing integrity, usability, and lifecycle compliance requirements across diverse delivery systems.

A strategic alliance accelerates the delivery of complex bioconjugates by integrating the entire drug substance and drug product manufacturing process into one streamlined solution.

Why take the risk of selecting components that may not work well together? This containment system, with proven container closure integrity, provides risk mitigation, convenience, and small quantities.

Explore how a suite of proprietary CDO platforms for BsAbs, transient expression, developability assessment, and more can optimize development and accelerate your project timeline.

Learn about a manufacturing site with over 35 years of expertise in bioconjugation, APIs, excipients, and adjuvants manufacturing that helps clients accelerate drug development programs worldwide.